comparemela.com

Latest Breaking News On - Tatva chintan pharma chem - Page 6 : comparemela.com

Gainers & Losers: 10 stocks that moved the most on May 8

Tatva Chintan Pharma Chem: September 22 Results Update

Tatva Chintan Pharma Chem (Tatva) continued its poor performance in Q2FY22-23. Revenue declined by 27% y-o-y (year-on-year) to Rs90 crore because sales of SDA (structure directing agent) declined by 88% y-o-y on disruption in auto production due to chip shortage and 50% drop in sales of heavy-duty diesel engine commercial vehicles (CVs) in China.

Midcap, smallcap stocks to buy: Tatva Chintan, SKF India, TVS Motor & Mas Financial

MCX, Bharat Forge, Axis Bank among 40 stocks where MFs raised stake in a year

Indian equities saw ferocious selling by foreign institutional investors (FIIs) amid the ongoing global economic concerns of crude and gas price hikes, rising inflation, and currency depreciation against the US dollar. Only in the first eight months of 2022 till August 31, FIIs have sold shares worth Rs 2.68 lakh crore in the Indian equity market.

Tatva Chintan Pharma Chem: June 22 Results Update

Tatva Chintan Pharma Chem (Tatva) reported poor numbers, yet again. Revenue declined by 17% y-o-y (year-on-year) and 10% q-o-q (quarter-on-quarter) to Rs88 crore.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.